Pazopanib in the Treatment of Bilateral Multifocal Renal Oncocytomas: A Case Report

Clin Genitourin Cancer. 2018 Jun;16(3):e509-e512. doi: 10.1016/j.clgc.2018.02.017. Epub 2018 Feb 23.

Authors

Matthew Labriola¹, Wen-Chi Foo², Daniel J George³, Tian Zhang⁴

Affiliations

¹ Department of Medicine, Duke University Medical Center, Durham, NC.
² Department of Pathology, Duke University Medical Center, Durham, NC.
³ Division of Medical Oncology, Department of Medicine, Duke Cancer Institute, Durham, NC.
⁴ Division of Medical Oncology, Department of Medicine, Duke Cancer Institute, Durham, NC. Electronic address: Tian.zhang2@duke.edu.

PMID: 29636282
DOI: 10.1016/j.clgc.2018.02.017

No abstract available

Keywords: Oncocytoma; Pazopanib; Renal preservation.

Publication types

Case Reports

MeSH terms

Adenoma, Oxyphilic / drug therapy*
Adenoma, Oxyphilic / surgery
Administration, Oral
Combined Modality Therapy
Humans
Indazoles
Kidney Neoplasms / drug therapy*
Kidney Neoplasms / surgery
Male
Middle Aged
Nephrectomy
Protein Kinase Inhibitors / administration & dosage*
Pyrimidines / administration & dosage*
Pyrimidines / therapeutic use
Sulfonamides / administration & dosage*
Sulfonamides / therapeutic use
Treatment Outcome

Substances

Indazoles
Protein Kinase Inhibitors
Pyrimidines
Sulfonamides
pazopanib

Supplementary concepts

Oncocytoma, renal